How immune cells detect and respond to mutations in cancer cells

byUniversity of California, Los AngelesScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDFor the first time, a r

Updated on: January 02,2024 9

How immune cells detect and respond to mutations in cancer cells

byUniversity of California, Los AngelesScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDFor the first time, a r

Updated on:January 02,2024 9

Team identifies key driver of cancer cell death pathway that activates immune cells

by University of Illinois at Urbana-ChampaignThe research team included, from left, research scientist Chengjian Mao, graduate student Xinyi Dai, biochemistry professor David Shapiro, graduate st

Updated on: February 23,2024 16

Team identifies key driver of cancer cell death pathway that activates immune cells

by University of Illinois at Urbana-ChampaignThe research team included, from left, research scientist Chengjian Mao, graduate student Xinyi Dai, biochemistry professor David Shapiro, graduate st

Updated on:February 23,2024 16

How post-feeding breasts bounce back from the brink of death to kick-start milk production

byUniversity of SheffieldDelayed alveolar regression in Rac1−/− glands in involution. (A-D) Carmine staining of whole-mounted mammary glands of WT (A, C) and Rac1−/− (B, D) mice at postlactation

Updated on: January 02,2024 16

How post-feeding breasts bounce back from the brink of death to kick-start milk production

byUniversity of SheffieldDelayed alveolar regression in Rac1−/− glands in involution. (A-D) Carmine staining of whole-mounted mammary glands of WT (A, C) and Rac1−/− (B, D) mice at postlactation

Updated on:January 02,2024 16

Levonorgestrel IUD feasible for low-risk, early uterine cancer

(HealthDay)—A levonorgestrel-releasing intrauterine device (LNG-IUD) is effective in the majority of patients undergoing conservative treatment for low-risk endometrial cancer and complex atypical hyp

Updated on: March 24,2024 18

Levonorgestrel IUD feasible for low-risk, early uterine cancer

(HealthDay)—A levonorgestrel-releasing intrauterine device (LNG-IUD) is effective in the majority of patients undergoing conservative treatment for low-risk endometrial cancer and complex atypical hyp

Updated on:March 24,2024 18

UK underwear gets cancer warning labels

Credit: CC0 Public DomainUK supermarket chain Morrisons said on Monday it had joined forces with the state-run National Health Service to put advice labels on underwear about the early warning signs o

Updated on: February 03,2024 14

UK underwear gets cancer warning labels

Credit: CC0 Public DomainUK supermarket chain Morrisons said on Monday it had joined forces with the state-run National Health Service to put advice labels on underwear about the early warning signs o

Updated on:February 03,2024 14

Differences found in how doctors, caregivers and patients report side effects of cancer therapy

by Children's Hospital Los AngelesCredit: CC0 Public DomainA recent study reveals differences in how symptom toxicity is reported for children receiving cancer treatment in clinical trials. D

Updated on: February 03,2024 11

Differences found in how doctors, caregivers and patients report side effects of cancer therapy

by Children's Hospital Los AngelesCredit: CC0 Public DomainA recent study reveals differences in how symptom toxicity is reported for children receiving cancer treatment in clinical trials. D

Updated on:February 03,2024 11

Disruption of immune cells in blood is linked to cancer outcomes, new tool reveals

Updated on: April 29,2025 0

Disruption of immune cells in blood is linked to cancer outcomes, new tool reveals

Updated on:April 29,2025 0

Some young cancer survivors face higher risk of premature heart failure

by Northwestern UniversityIncident Heart Failure Among YA Cancer Survivors (A) Comparison of history of anthracycline treatment vs none. (B) Stratified by young adult (YA) cancers commonly treate

Updated on: February 03,2024 14

Some young cancer survivors face higher risk of premature heart failure

by Northwestern UniversityIncident Heart Failure Among YA Cancer Survivors (A) Comparison of history of anthracycline treatment vs none. (B) Stratified by young adult (YA) cancers commonly treate

Updated on:February 03,2024 14

Dietary supplement helps combat resistance in breast cancer, finds study

byUniversity of BaselCredit: Unsplash/CC0 Public DomainMany cancer therapies do not produce the hoped-for results. A common reason for this is that the tumors develop resistance to the medicatio

Updated on: January 23,2024 18

Dietary supplement helps combat resistance in breast cancer, finds study

byUniversity of BaselCredit: Unsplash/CC0 Public DomainMany cancer therapies do not produce the hoped-for results. A common reason for this is that the tumors develop resistance to the medicatio

Updated on:January 23,2024 18

Researchers discover a weakness in a rare cancer that could be exploited with drugs

by Rockefeller UniversitySome cancer cells cannot produce cholesterol, and instead build up an excess of squalene (pink)--a molecule that may help these dangerous cells thrive. Credit: Laboratory

Updated on: June 19,2024 5

Researchers discover a weakness in a rare cancer that could be exploited with drugs

by Rockefeller UniversitySome cancer cells cannot produce cholesterol, and instead build up an excess of squalene (pink)--a molecule that may help these dangerous cells thrive. Credit: Laboratory

Updated on:June 19,2024 5

Drug approved to help young patients battle a rare cancer

by Cara Murez HealthDay ReporterChildren and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact.The U.S. Food and Drug Administration has&n

Updated on: February 01,2024 19

Drug approved to help young patients battle a rare cancer

by Cara Murez HealthDay ReporterChildren and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact.The U.S. Food and Drug Administration has&n

Updated on:February 01,2024 19

Research finds that life-saving intervention is not risk-free in pediatric patients

by Rachel Sauer,CU Anschutz Medical CampusCredit: Unsplash/CC0 Public DomainBlood transfusion is a vital and lifesaving intervention in a broad range of scenarios, from trauma response to cancer

Updated on: January 23,2024 11

Research finds that life-saving intervention is not risk-free in pediatric patients

by Rachel Sauer,CU Anschutz Medical CampusCredit: Unsplash/CC0 Public DomainBlood transfusion is a vital and lifesaving intervention in a broad range of scenarios, from trauma response to cancer

Updated on:January 23,2024 11